Novartis AG (NOVN.SW) — Technical state
As of 2026-11-20 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.
The Closelooknet read
- Closelooknet score: 58 out of 100 (momentum 74 · quality 82 · valuation 39), as of 2026-11-21.
- Signal: Uptrend stack intact — Trades +2.4% vs the 50-day and +4.5% vs the 200-day average, 6.7% below the 52-week high and +32.4% off the 52-week low. Computed from daily closes. (as of 2026-11-20)
- Trend: Novartis AG trades 2.4% above its 50-day and 4.5% above its 200-day moving average. (as of 2026-11-20)
- Index seat: AI Users Index
Novartis researches, makes and sells prescription medicines, covering heart failure, psoriasis and other immune conditions, several cancers, cholesterol management and a gene therapy for spinal muscular atrophy. It groups its work into cardiovascular, renal and metabolic disease, immunology, neuroscience, oncology and blood disorders.
The full read — the desk's view, the earnings record, peers and the company snapshot — is on the NOVN.SW overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.
Trades +2.4% vs the 50-day and +4.5% vs the 200-day average, 6.7% below the 52-week high and +32.4% off the 52-week low. Computed from daily closes.
The moving-average stack
- vs 20-day-3.2%
- vs 50-day+2.4%
- vs 200-day+4.5%
- 52-week band6.7% off the high · +32.4% off the low
- Streak1 consecutive up session
- 50-day crossprice crossed up through the 50-day 27 sessions ago
- Stochastic%K 9.8 · %D 23.6
Continue: the NOVN.SW chart & overview · quality & forensics · the signal board
FAQ · from the current data · as of 2026-11-20
Quick answers
What is the current Closelooknet signal on NOVN.SW?
Uptrend stack intact — Trades +2.4% vs the 50-day and +4.5% vs the 200-day average, 6.7% below the 52-week high and +32.4% off the 52-week low. Computed from daily closes. As of 2026-11-20; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.
Is NOVN.SW above its 50-day and 200-day moving averages?
As of 2026-11-20, Novartis AG trades +2.4% above its 50-day and +4.5% above its 200-day average, with the 20-day -3.2% away.
How far is NOVN.SW from its 52-week high?
6.7% below the 52-week high and 32.4% above the 52-week low, as of 2026-11-20.
Related in the Closelooknet universe
- HALO Halozyme Therapeutics Incsector
- ONC BeOne Medicines AGsector
- REGN Regeneron Pharmaceuticals Incsector
- UCB.BR UCB SAsector
- ARGX.BR Argen-Xsector
- LLY Eli Lilly and Companysector
- ANN.AU Ansell Ltdsector
- ARGX argenx NV ADRsector
- ROVI.MC Laboratorios Farmaceuticos ROVIsector
- ORNAV.HE Orion Oyj Asector
- ORNBV.HE Orion Oyj Bsector
- RIGL Rigel Pharmaceuticals Incsector
- SAN.PA Sanofi SAsector
- DXCM DexCom Incsector
- HQY HealthEquity Incsector
- MEDP Medpace Holdings Incsector
- PTGX Protagonist Therapeutics Incsector
- CEVI.ST CellaVision ABsector
- FPH.AU Fisher & Paykel Healthcare Corporation Ltdsector
- GMED Globus Medicalsector